Clocinnamox
 ![]()  | |
| Names | |
|---|---|
|  IUPAC name
 (E)-N-[(4R,4aS,7aR,12bR)-3-(Cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]-3-(4-chlorophenyl)prop-2-enamide  | |
|  Other names
 Chlorocinnamoylaminodihydronormorphinone  | |
| Identifiers | |
| ChEMBL | ChEMBL386492 | 
| ChemSpider | 5022878 | 
| Jmol interactive 3D | Image | 
| PubChem | 6540640 | 
 
  | |
 
  | |
| Properties | |
| C29H29ClN2O4 | |
| Molar mass | 505.01 g·mol−1 | 
|   Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  | |
| Infobox references | |
Clocinnamox is a selective, irreversible μ-opioid receptor antagonist.[1]
References
- ↑ Filho, CB; Del Fabbro, L; De Gomes, MG; Goes, AT; Souza, LC; Boeira, SP; Jesse, CR (2013). "Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test". European Journal of Pharmacology 698 (1–3): 286–91. doi:10.1016/j.ejphar.2012.11.003. PMID 23178563.
 
This article is issued from Wikipedia - version of the Saturday, January 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
